Delivery Order SPE2DR25D3013-SPE2DR26F6V0D
Award Date 12/16/25
Potential Completion Date 12/17/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $30,465.45 for Mounjaro 5 mg/0.5 ml pen injections on December 10, 2025, with a completion date of December 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a tirzepatide-based pharmaceutical used for diabetes management, consistent with...
- The Defense Logistics Agency awarded a $61,157.01 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen injectors on November 24, 2025, with an ultimate completion date of November 25, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a tirzepatide injection used for diabetes management, reflecting the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections valued at $1,090.85 on December 12, 2025, with completion scheduled for December 15, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a tirzepatide-based diabetes medication, consistent with...
- The Defense Logistics Agency awarded a delivery order valued at $4,616.23 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pen injections on December 9, 2025, with completion scheduled for December 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a tirzepatide-based medication used for diabetes management, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $44,586.36 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 ml pen injectors on September 29, 2025. This is a firm fixed-price, non-set-aside contract with a completion date of September 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a tirzepatide-based diabetes medication used for glycemic control in patients with type 2 diabetes. This...
- The Defense Logistics Agency awarded a delivery order valued at $108,836.00 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 ml pen injectors on September 15, 2025. This firm fixed-price contract, with an ultimate completion date of September 16, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Mounjaro is a tirzepatide-based...
- The Defense Logistics Agency awarded a delivery order valued at $6,904.42 to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen injectors on November 24, 2025, with completion expected by November 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Mounjaro is a GLP-1 receptor agonist used in diabetes and weight management treatment,...
- The Defense Logistics Agency awarded a $7,501.37 delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pens on December 9, 2025, with completion targeted for December 10, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. Mounjaro is a tirzepatide injection used primarily for diabetes management, representing a critical pharmaceutical supply for military...
- The Defense Logistics Agency awarded a delivery order valued at $43,363.77 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pen injectors on November 18, 2025, with completion scheduled for November 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes treatment medication, consistent with...
- The Defense Logistics Agency awarded a delivery order valued at $24,855.50 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pen injections on September 10, 2025, with completion scheduled for September 11, 2025. This firm fixed-price, non-set-aside delivery order represents a routine pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support...